$37.79
▲ +0.0% Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
CareDx (CDNA) Is Up 39.4% After Medicare Clarifies Transplant Test Coverage Limits - What's Changed
CareDx (CDNA) Secures Medicare Reimbursement Clarity, Is The Upside Already Priced In?
CareDx (CDNA) Stock May Be Fully Valued Despite Medicare Coverage News
Overview
52-week range
$11
$24
100% of range
Avg surprise (last 2)
-18.0%
Avg reaction (last 1)
-6.9%
0% positive
Latest IV / EM
65%
EM ±14.9% · $40 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.05 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.03 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-0.16 | $-0.11 | -45.5% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $-0.19 | $-0.21 | +9.5% | — | -6.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.20 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.09 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.38 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.43 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.46 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 30, 2026 | Jun/2026 | AMC | — | -$0.16 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $1M | — | $-246,000 | $-11M | $-13M | — | $-14M | $-7M |
| Net income | $3M | — | $2M | $-9M | $-10M | — | $-11M | $-5M |
| EPS (diluted) | $0.05 | — | $0.03 | $-0.16 | $-0.19 | — | $-0.20 | $-0.09 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $78M | $65M | $91M | $68M | $89M | $115M | $95M | $96M |
| Inventory | $26M | $27M | $28M | $28M | $23M | $20M | $19M | $19M |
| Total current assets | $269M | $257M | $300M | $307M | $350M | $352M | $334M | $321M |
| Total assets | $411M | $413M | $432M | $444M | $490M | $491M | $477M | $467M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $98M | $110M | $121M | $117M | $110M | $113M | $204M | $202M |
| Total equity | $314M | $303M | $311M | $327M | $379M | $378M | $273M | $265M |